Coxiella burnetii is a strictly intracellular bacterium. Bacteriostatic effects have been described previously on a few isolates in embryonated eggs (A. J. Spicer, M. G. Peacock, and J. C. Williams, p. 375-383, in W. Burgdorfer and R. L. Anacker, ed., Rickettsiae and rickettsial diseases, 1981). We used the shell-vial technique (D. Raoult, G. Vestris, and M. Enea, J. Clin. Microbiol. 28:2482Microbiol. 28: -2484Microbiol. 28: , 1990) to determine the susceptibility of C. burnetii to amoxicillin, amikacin, erythromycin, co-trimoxazole, pefloxacin, ofloxacin, ciprofloxacin, chloramphenicol, tetraycline, doxycycline, minocycline, and rifampin antibiotics at a single dilution. Human embryonic lung fibroblast monolayers in shell vials were seeded with 13 different C. burnetii isolates, including 3 reference strains (Nine Mile, Q212, and Priscilla) and 10 new isolates, in order to obtain 30% infected cells 6 days later. After inoculation, antibiotics were added, shell vials were incubated for 7 days, and immunofluorescence was revealed and compared with that of the positive controls. Strain Nine Mile was more susceptible than strains Q212 and Priscilla were. The heterogeneity of susceptibility to fluoroquinolones, chloramphenicol, and erythromycin was noted among the strains; all were resistant to amoxicillin and amikacin, and all were susceptible to rifampin, co-trimoxazole, tetracycline, and tetracycline analogs.
Q fever is a widespread disease caused by Coxiella burnetii. Two major forms of the disease are known: acute and chronic, which includes endocarditis. The clinical form of the disease is related both to host factors (14) and to strain specificity (5) . It has been reported that strains isolated from patients with endocarditis are different from those isolated from patients with the acute form of disease (22, 23) . Acute Q fever is a self-limiting disease, and bacteriostatic antibiotic therapy is sufficient in these cases in order to shorten the duration of disease. Chronic Q fever is a severe, frequently lethal disease in which C. burnetii survives and the disease can relapse despite years of antibiotic treatment (3, 6-8, 10, 13, 16-18, 26-31) . In these cases, a bacteriocidal activity is also required, but such activity has not been shown by the use of single-drug therapy in vitro (14) . For antibiotic susceptibility testing, embryonated eggs (2, 9, 24, 32) and cell cultures (34) have been used. These techniques are timeconsuming and conveniently allow the testing of only a few antibiotics with a few isolates. We describe here a new antibiotic testing method which determines the bacteriostatic activity of antibiotic compounds by the newly described shell-vial technique (19) . By this method, we compared the bacteriostatic effects of 12 antibiotic compounds on 3 reference isolates and 10 new human isolates of C. burnetii.
MATERIALS AND METHODS
C. burnetii isolates. The Nine Mile isolate, which is the reference isolate for acute infection (5), was obtained from 0. Baca (University of New Mexico, Albuquerque). The Q212 and Priscilla isolates (from a goat), which are reference strains (5) for chronic infection, were obtained from T. Hackstadt (Rocky Mountain Laboratory, Hamilton, Mont.). The other 10 isolates were obtained from eight cardiac valves (ME), a vascular aneurysm (MAN), and a vascular * Corresponding author. prosthesis (MP) in patients suffering from chronic Q fever. C. burnetii isolation was performed by inoculating the homogenates of infected cardiac valves on human embryonic lung fibroblasts (HEL cells) in centrifugation shell vials as described previously (19) .
In vitro cultivation of C. burnetii. The C. burnetii isolates examined in this study were named M (for Marseille), E (for endocarditis), AN (for aneurism), P (for prosthesis), and I (for immunocompromised) and were numbered from 1 to 10. All C. burnetii isolates were cultivated on HEL cells grown in antibiotic-free Eagle minimal essential medium supplemented with 1% glutamine and 10% fetal calf serum at 37°C in a 10% CO2 incubator. The cells were passaged until 90% of the cells were infected, as determined by Gimenez staining. An inoculum was then prepared from each isolate.
Antibiotic preparation. Chloramphenicol (Roussel, Paris, France), tetracycline (HCl) (Diamant, Puteaux, France), minocycline chlorhydrate (Lederle, Oullins, France), erythromycin (Roussel, Paris, France), rifampin (Merrel Dow, Neuilly/Seine, France), amoxicillin (Beecham Sdvignd, Paris, France), amikacin (Bristol, Paris, France), doxycycline (Pfizer, Orsay, France), sulfamethoxazole-trimethoprim (400 and 80 mg, respectively; Roche, Neuilly/Seine, France), pefloxacin (Roger Bellon, Neuilly/Seine, France), ofloxacin (Diamant, Puteaux, France), and ciprofloxacin (Bayer Pharma, Sens, France) were used in the study.
For each antibiotic compound, a stock solution at 1.0 mg/ml was prepared by using methanol for chloramphenicol, erythromycin, and rifampin powder; distilled sterile water for tetracycline and minocycline chlorhydrate powder; or the solvents supplied by the manufacturer and sterile distilled water for the other antibiotics. At the concentrations used, the solvents were nontoxic to normal or 4 . To obtain these concentrations, appropriate amounts of the antibiotic stock solutions were diluted with the cell culture medium to obtain an end volume of 0.1 ml. For each C. burnetii isolate, a series of centrifugation shell vials was inoculated with the dilution of infected cell suspension that resulted in 30 to 50% of the cells becoming infected after 6 days in the inoculum titration test. After centrifugation, the supernatant was decanted and 0.1 ml of the antibiotic solution and 0.9 ml of the cell culture medium were added to each shell vial. In addition, for each isolate, a reference shell vial of infected HEL cells without antibiotics (positive control) was prepared. After 6 days at 37°C in a CO2 incubator, the number of HEL cells infected with C. burnetii was determined by indirect immunofluorescence (Fig. 2) .
Indirect immunofluorescence to C. burnetii. HEL cells were fixed in the shell vials for 10 min with methanol, rehydrated for 5 min in phosphate-buffered saline (PBS), and incubated for 30 min at 37°C with 0.3 ml of anti-C. burnetii rabbit serum (titer, 2,000) diluted (1:200) in PBS. The cells were rinsed and washed three times (10 min each time), and were incubated for 30 min at 37°C with 0.3 ml of goat anti-rabbit globulin that was fluorescein conjugated (Bio-Mdrieux, Charbonni6res-les-Bains, France) and were diluted (1:300) in PBS wi'th Evans Blue (1:4,000) as a counter stain. After rinsing and washing three times in PBS, the coverslips from the shell vials were mounted in buffered glycerol on microscope slides and read with a fluorescence microscope.
Test reading. The C. burnetii organisms could be observed by their intense yellow-green fluorescence inside one or more phagolysosomal vacuoles of the infected cells. For each isolate, the effect of an antibiotic compound was assessed by comparison with the reference infection obtained without antibiotic and a negative control (fixation of the slide immediately after inoculation with each isolate). The results were scored as follows ( Fig. 3) 35, 1991 .} Actions of the antibiotics. Tables 2 and 3 show the efficacies of the antibiotics against the different isolates tested by the shell-vial technique.
Reproducibility and reading of discrepancies. The independent investigators (D.R. and H.T.) obtained the same results in all the tests. The 65 new tests were read blindly (13 positive controls; 13 negative controls; and 13 tested with pefloxacin, ofloxacin, and ciprofloxacin). The results obtained by the independent readers were in agreement for all negative or''susceptible ( (Fig. 4) . All isolates of C. burnetii were found to be resistant to amoxicillin and amikacin. Erythromycin at 1 ,ug/ml showed no effect on six isolates, but slowed the multiplication of the remaining seven isolates. The quinolone ciprofloxacin was bacteriostatic for five isolates; the other eight isolates partially escaped its action. The ofloxacin and pefloxacin were more effective. Chloramphenicol was effective against 10 strains, but in three cases, the multiplication of C. burnetii was not fully inhibited. Tetracycline and its analogs, rifampin, and co-trimoxazole prevented any isolate from multiplying in HEL cells. Partial resistance to ciprofioxacin was frequently observed in our model. This often correlated with lower susceptibilities of the isolates to other antibiotic compounds such as erythromycin. None of the C. burnetii isolates tested was resistant to tetracycline or its analogs or to rifampin. Co-trimoxazole allowed the persistence of some isolates, which became elongated (Fig. 4) .
A group of five isolates (Nine Mile, ME1, ME3, MP7, and ME8) was susceptible to ciprofloxacin and chloramphenicol. Among these, four isolates were partly susceptible to erythromycin. Five strains (Priscilla, ME2, ME5, ME6, and MEI10) were resistant to ciprofloxacin but were susceptible to chloramphenicol. The last three strains (Q212, ME4, and ME9) had the most resistance and were also resistant to chloramphenicol.
DISCUSSION
Acute and chronic forms of Q fever are distinct by their symptomatology and prognosis. The acute form has a broad spectrum of clinical features and may be inapparent (5, 14) . While endocarditis is the most frequent feature of chronic Q fever, which is a severe disease (6, 26, 29, 30) , it is frequently fatal, despite antibiotic treatment. The diagnosis is confirmed by serologic demonstration of immunoglobulin G and A antibodies to phase I C. burnetii (11, 19) . The severity of Q fever may be related to host factors, because chronic endocarditis mainly occurs in immunocompromised patients or those with previous valvular damage (14, 16) . The patho- genicity of C. burnetii may be related to the genetic heterogenicity of the different isolates (22, 23) . The results of antibiotic susceptibility testing of C. burnetii in vitro depend on the model used and the strains tested (15, 20, 21, (33) (34) (35) . Reports on the heterogenicity of antibiotic susceptibility among different strains have been made (24, 33) , but these were determined for only a limited number of strains.
Suspecting antibiotic susceptibility heterogenicity, in this study we compared the bacteriostatic effects of 12 antibiotics on 3 reference isolates and 10 new human isolates of C. burnetii implicated in chronic Q fever endocarditis. The variation in the number of bacteria inoculated needed to 
a S, susceptible (no growth); R, resistant (normal growth).
obtain the reference infection in our model was comparable to that needed to achieve toxicity of different C. burnetii strains in chick embryos (5). The Nine Mile strain was very infectious in both models. The test could be easily read with regard to resistance and susceptibility. As for decreased or intermediate susceptibility, tests discrepancies may occur when a strict definition of susceptibility that includes pictures for comparison ( Fig. 3 and 4) is not provided. One must be careful of the interpretation and use Fig. 3 and 4 (19) . There was no difference between tetracycline and its analogs in our model, with all being efficient at 4 ,ug/ml. The efficacy of co-trimoxazole has been reported to be related to that of trimethoprim (24) . The heterogenicity of susceptibility among C. burnetii isolates noted in this study was represented by differences in susceptibilities to ciprofloxacin and chloramphenicol. The endocarditis-associated isolates were distributed in three patterns of susceptibility. The first pattern included the most susceptible isolates (4 of 10), together with the Nine Mile strain. They were susceptible to ciprofloxacin and chloramphenicol. In the second group, isolates were intermediate to ciprofloxacin but were susceptible to chloramphenicol; this group included the strain Priscilla. In group 3, isolates were intermediate to ciprofloxacin and chloramphenicol; this group included strain Q212. Differences in antibiotic susceptibility between the Nine Mile and Priscilla isolates have been reported previously (35) . In infected L929 cells, Priscilla was less susceptible to rifampin (1 ,ug/ml) and quinolones (5 ,ug/ml) than the Nine Mile strain was (35) . In our model, this difference was shown with ciprofloxacin at 1.0 ,ug/ml, but rifampin at 4 ,ug/ml did not allow any distinction between the susceptibilities of isolates. We did not observe any resistance to tetracycline or its analogs, although a less susceptible strain has been shown in embryonated eggs (24) . This is the first report of resistance to chloramphenicol among C. burnetii isolates.
The heterogenicity of susceptibility of the isolates from humans implicated in endocarditis must be considered in the treatment of chronic Q fever. Tetracycline, the reference treatment (11) , is clinically effective when it is used alone (12) , but it does not sterilize the infection. Combinations of antibiotics with tetracycline or its analogs are used. Satisfactory results against Q fever endocarditis have been obtained with co-trimoxazole combined with tetracycline (4) . Also, combinations of tetracycline or doxycycline with rifampin have been used successfully (16) , but the association of rifampin with co-trimoxazole gave ambivalent results (25) . Regimens that combine tetracycline with quinolones have been recommended in the treatment of chronic Q fever, after the demonstration of the efficacy of quinolones against C. burnetii in vitro (36) . However, these antibiotics failed to eliminate the infection, and excised cardiac valves contained viable C. burnetii (19) . Clinically, however, there does appear to be some benefit in combining pefloxacin or ofloxacin with doxycycline (16) . The reasons for the failure of antibiotic therapy against chronic Q fever may be the absence of bacteriocidal activity of the antibiotics used (14) or the susceptibility of the isolates to antibiotics. Indeed, according to our criteria, certain isolates implicated in human endocarditis are less susceptible to antibiotics, especially to the quinolone ciprofloxacin. Therefore, in patients suffering from chronic Q fever, it may be important to check the antibiotic susceptibility of the isolate involved.
Our work showed the heterogenicity of antibiotic susceptibility among the C. burnetii isolates implicated in human Q fever endocarditis. Six isolates with decreased susceptibility to ciprofloxacin were noted. The susceptible isolates had the same pattern as Nine Mile, the reference isolate for the acute infection. The shell-vial technique allowed us to determine relatively quickly the antibiotic susceptibility of the isolate implicated in endocarditis, and it will be useful in the treatment of chronic Q fever.
